Neutrophilia as prognostic factor for outcome in the CAO/ARO/ALO-04 phase 3 rectal cancer trial

Conference contribution


Publication Details

Author(s): Diefenhardt M, Hofheinz R, Beissbarth T, Arnold D, Von Den Gruen JM, Liersch T, Stroebel P, Grabenbauer G, Fietkau R, Weitz J, Ghadimi M, Roedel C, Fokas E
Publisher: ELSEVIER IRELAND LTD
Publishing place: CLARE
Publication year: 2019
Conference Proceedings Title: RADIOTHERAPY AND ONCOLOGY
Pages range: S256-S257
ISSN: 0167-8140


FAU Authors / FAU Editors

Fietkau, Rainer Prof. Dr.
Lehrstuhl für Strahlentherapie


External institutions with authors

DiaCura - Praxis für Radiologische Diagnostik, Strahlentherapie und Radioonkologie
HELIOS Kliniken
Technische Universität Dresden
Universitätsklinikum Frankfurt
Universitätsklinikum Göttingen
Universitätsklinikum Mannheim


How to cite

APA:
Diefenhardt, M., Hofheinz, R., Beissbarth, T., Arnold, D., Von Den Gruen, J.M., Liersch, T.,... Fokas, E. (2019). Neutrophilia as prognostic factor for outcome in the CAO/ARO/ALO-04 phase 3 rectal cancer trial. In RADIOTHERAPY AND ONCOLOGY (pp. S256-S257). Milan, IT: CLARE: ELSEVIER IRELAND LTD.

MLA:
Diefenhardt, M., et al. "Neutrophilia as prognostic factor for outcome in the CAO/ARO/ALO-04 phase 3 rectal cancer trial." Proceedings of the 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan CLARE: ELSEVIER IRELAND LTD, 2019. S256-S257.

BibTeX: 

Last updated on 2019-21-06 at 09:08